Experience

Guardant Health

• United States
• Biotechnology Research
• 700 & Above Employee

• Director of Medical Strategy and Publications

  • Aug 2023 - Present

• Senior Medical Science Liaison

  • Oct 2021 - Aug 2023

• Medical Science Liaison II

  • Jul 2019 - Oct 2021

  As an MSL at Guardant Health, I focus on educating oncologists on the utility of liquid biopsy to perform comprehensive genomic profiling on advanced cancer patients, especially when tissue biopsy in not feasible, or insufficient for NGS. I support KOLs by assisting with clinical report interpretation, investigator-initiated clinical and translational research studies, scientific abstract and manuscript preparation, and providing updates on recent NCCN guideline and FDA approvals that may be… Show more As an MSL at Guardant Health, I focus on educating oncologists on the utility of liquid biopsy to perform comprehensive genomic profiling on advanced cancer patients, especially when tissue biopsy in not feasible, or insufficient for NGS. I support KOLs by assisting with clinical report interpretation, investigator-initiated clinical and translational research studies, scientific abstract and manuscript preparation, and providing updates on recent NCCN guideline and FDA approvals that may be helpful for clinical decision making.



NantHealth

• United States
• Hospitals and Health Care
• 100 - 200 Employee

• Medical Science Liaison

  • Jun 2018 - Jul 2019

  As an MSL, I provide scientific expertise on molecular diagnostic platforms, including GPS Cancer and Liquid GPS, establish and foster relationships with KOLs and medical oncologists, provide support to medical oncologists by interpreting genomic findings, help them understand patient disease biology, and identify potential treatment strategies and clinical trials. I enjoy presenting scientific and clinical research performed within the company to current and potential customers, perform… Show more As an MSL, I provide scientific expertise on molecular diagnostic platforms, including GPS Cancer and Liquid GPS, establish and foster relationships with KOLs and medical oncologists, provide support to medical oncologists by interpreting genomic findings, help them understand patient disease biology, and identify potential treatment strategies and clinical trials. I enjoy presenting scientific and clinical research performed within the company to current and potential customers, perform internal research projects for publication and presentation at national and international conferences, and collaborate with leadership to enhance marketing, messaging, strategy, and partnerships. Show less As an MSL, I provide scientific expertise on molecular diagnostic platforms, including GPS Cancer and Liquid GPS, establish and foster relationships with KOLs and medical oncologists, provide support to medical oncologists by interpreting genomic findings, help them understand patient disease biology, and identify potential treatment strategies and clinical trials. I enjoy presenting scientific and clinical research performed within the company to current and potential customers, perform… Show more As an MSL, I provide scientific expertise on molecular diagnostic platforms, including GPS Cancer and Liquid GPS, establish and foster relationships with KOLs and medical oncologists, provide support to medical oncologists by interpreting genomic findings, help them understand patient disease biology, and identify potential treatment strategies and clinical trials. I enjoy presenting scientific and clinical research performed within the company to current and potential customers, perform internal research projects for publication and presentation at national and international conferences, and collaborate with leadership to enhance marketing, messaging, strategy, and partnerships. Show less



University of Florida

• United States
• Higher Education
• 700 & Above Employee

• Research Assistant Professor

  • Jun 2017 - Jun 2018

  As a Research Assistant Professor of hematology oncology, I study molecular and genetic mechanisms of drug sensitivity and resistance in a variety of hematological malignancies including myelodysplastic syndromes, acute myeloid leukemia, multiple myeloma, chronic lymphoid leukemia, and others. I am also developing and applying sensitive genetic tests to monitor patient response to therapy using non-invasive methods, with a goal of reducing the number of painful bone marrow biopsies these… Show more As a Research Assistant Professor of hematology oncology, I study molecular and genetic mechanisms of drug sensitivity and resistance in a variety of hematological malignancies including myelodysplastic syndromes, acute myeloid leukemia, multiple myeloma, chronic lymphoid leukemia, and others. I am also developing and applying sensitive genetic tests to monitor patient response to therapy using non-invasive methods, with a goal of reducing the number of painful bone marrow biopsies these patients endure during their treatment.

• Scientific Director

  • Aug 2015 - Jun 2018

  iCare for Cancer Patients is a precision oncology clinical trial for patients with hematological malignancies with the goal of using genomics-informed computational biology to predict patient response to therapy. Accomplishments: ∙ Directed patient recruitment, sample collection and processing, data management, and dissemination of results ∙ Established and optimized a next-generation sequencing and interpretation workflow with accelerated turn around time ∙ Interpreted complex… Show more iCare for Cancer Patients is a precision oncology clinical trial for patients with hematological malignancies with the goal of using genomics-informed computational biology to predict patient response to therapy. Accomplishments: ∙ Directed patient recruitment, sample collection and processing, data management, and dissemination of results ∙ Established and optimized a next-generation sequencing and interpretation workflow with accelerated turn around time ∙ Interpreted complex genetic information to clinicians and healthcare professionals ∙ Performed computational biology modeling on genomic information to predict clinical response to therapy with high accuracy ∙ Designed and developed a database to house clinical and genomic information ∙ Presented data at national and international conferences

• Academic Tutor

  • Aug 2013 - Dec 2015

  I tutored University of Florida's student athletes in science courses such as biology, microbiology, genetics, and applied physiology. I was responsible for preparing tutor sessions, study outlines, practice tests, and promoting academic success.

• Pre-doctoral Fellow

  • Aug 2010 - Aug 2015

  I received my PhD in 2015 and studied the bone marrow microenvironment's protection of acute myeloid leukemia cells from chemotherapy. During my fellowship, I performed independent research, presented at national and international meetings, and formed meaningful collaborations within the hematology malignancy field.